Watch Peter Block, MD, FACC and Steven E. Nissen, MD, MACC discuss results from the GAUSS-3 Trial.

Keywords: ACC Annual Scientific Session, Antibodies, Monoclonal, Cholesterol, HDL, Cholesterol, LDL, Creatine Kinase, Dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Injections, Subcutaneous, Lipoprotein(a), Metabolic Syndrome, Primary Prevention, Proprotein Convertases, Risk Factors, Subtilisins, Triglycerides

< Back to Listings